Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chinese Medicine (United Kingdom) is Scopus-indexed (Q1, CiteScore 10.4), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1749-8546Verify ISSN ↗1991-0150Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 6 / 115 | 95th | Q1 |
| Pharmacology | 34 / 328 | 89th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q1, CiteScore 10.4.
Chinese Medicine (United Kingdom) is Q1 in Complementary and Alternative Medicine (rank 6 of 115) and Q1 in Pharmacology (rank 34 of 328), by CiteScore 2025.
Chinese Medicine (United Kingdom) is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.4, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.298, quartile Q1, with an H-index of 75.
The publisher lists an article processing charge of about US$2,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Chinese Medicine (United Kingdom) is published by BioMed Central Ltd. Its print ISSN is 1749-8546 and its online ISSN is 1991-0150.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Chinese Medicine (United Kingdom) has an h-index of 88 and a 2-year mean of 7.2 citations per paper (OpenAlex). Its Scopus CiteScore is 10.4, quartile Q1. On 2-year citations it ranks #4 of 109 Scopus journals in Complementary and Alternative Medicine.
Chinese Medicine (United Kingdom) published 217 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (91.6%), Macao SAR China (2.4%) and Hong Kong SAR China (1.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.